-
Saccadic and Smooth Pursuit Derangements in Essential Tremor: A Video Oculography Study
-
Safety and efficacy of focused ultrasound staged bilateral thalamotomy for Essential tremor
-
Safety and efficacy of istradefylline, an adenosine A2A receptor antagonist, as a function of baseline dyskinesia (BL-dyskinesia) in Parkinson’s disease (PD): A pooled analysis of 4 studies
-
Safety and Tolerability of Burst Cycling Deep Brain Stimulation for Freezing of Gait in Parkinson’s Disease
-
Safety, Tolerability, and Pharmacodynamic Profile of DNL201 at dose levels demonstrating LRRK2 inhibition in Parkinson’s Disease Patients with and without LRRK2 mutations
-
Salivary proteome in Parkinson’s disease
-
Satisfaction and impact on quality of life in patients with essential tremor treated with High Intensity Focused Ultrasound (HIFU) thalamotomy
-
Say “AH~”: Vocal Analysis in Parkinson’s Disease and Essential Tremor
-
SCA48: Ataxia Plus Chorea in a New Spanish Family
-
Screening of mutations in PARK2 gene and Dopamine levels in Parkinson’s disease (PD) patients in Coimbatore population, India
-
Secondary Vascular Parkinsonism: Role of increasing levels cortisol in the cognitive impairment
-
Selective α-synuclein overexpression-induced pathology in noradrenergic neurons: a new mouse model for prodromal Parkinson’s disease?
-
Self-perceived stigma and motor symptoms in patients with Parkinson’s disease
-
Self-Perception of Dysphagia Before and After Botulinum Toxin Injection for Cervical Dystonia
-
Sensitive biomarker of Parkinson’s disease linked to mutations in the glucocerebrosidase gene
-
Sensor-Based Gait Measurements Predict Subthalamic Deep Brain Stimulation Frequency in Parkinson’s Disease Patients – A Proof of Concept Study
-
Sensorimotor inhibition relates to gait dysfunction in people with Parkinson’s disease
-
Sensory Trick in Oromandibular and Tongue Dystonia in Patient with Wilson’s Disease
-
Serious games home rehabilitation program to treat gait and balance disorders in patients with Parkinson’s disease: A randomised controlled trial
-
Serum microRNA expression levels in Turkish patients with Parkinson’s disease
-
Serum microRNA-29 family as potential biomarkers for cognitive impairment in Parkinson’s disease
-
Serum molecular markers and non-motor symptoms in Parkinson’s disease
-
Serum neurofilament light chain differentiates early Parkinson’s disease from progressive supranuclear palsy-parkinsonism
-
Serum Neurofilament light chain levels and disability milestones in Lewy body diseases
-
Severity of Motor Symptoms in Parkinson’s Disease in Kazakhstan (on the example of the city of Almaty)
-
Sex differences on dynamic functional connectivity in Parkinson’s disease and healthy controls
-
Sex Moderates the Effects of Neurofibrillary Tangles on Cognition for Diffuse Lewy Body Pathology
-
Sex-associated difference in the presentation and progression of Parkinson’s disease
-
Sex-related disease differences in Parkinson’s disease
-
Sex-related longitudinal change of motor features and biological biomarkers in early Parkinson’s disease from the PPMI cohort
-
Sex-specific neuroprotection by inhibition of the Y-chromosome gene, SRY, in experimental Parkinson’s disease
-
Sex-specific white matter alterations in Parkinson’s disease with mild cognitive impairment
-
Sexual Dysfunction Among Patients with Parkinson’s Disease in Dakar Senegal
-
Sexual dysfunction associated with deep brain stimulation of the Globus Pallidus pars interna
-
Sexual dysfunction precedes the classical motor symptoms of Parkinson’s disease?
-
Shear wave sonoelastography is effective in detecting myofascial trigger points and spasticity
-
Short digitalized cognitive test help differentiating Parkinson’s disease (PD) patients with and without Mild Cognitive Impairment (MCI)
-
Short- and Long-term Healthcare Resource Utilization in Parkinson’s Disease – 20 years of Follow Up in a Population-based Cohort
-
Significant hypometabolism in the posterior parietal cortex and precuneus in Parkinson’s disease with GBA mutations: [18F]FDG PET study
-
Simultaneous, levodopa-responsive Holmes’ tremor and hemiparkinsonism due to midbrain cavernous malformation
-
Single-energy Metal Artefact Reduction: a Precise Method for Localization of Deep Brain Stimulation Electrodes in Parkinson’s Patients
-
Site investigator perspectives on exclusionary determinations of SWEDDs (Scans Without Evidence of Dopaminergic Deficit) during screening in the SURE-PD3 study
-
SLC20A2 mutation manifesting as very-late onset orofacial dyskinesia
-
Sleep and Polysomnographic Abnormalities in Indian Patients with Huntington’s Disease
-
Sleep disturbances in Vascular Parkinsonism (VP) and Parkinson’s Disease (PD) patients in early stages
-
Sleep Disturbances in Young Onset Parkinson’s Disease
-
Sleep Patterns in Relation to Disease Severity in Parkinson’s Disease: A Study of 84 Ibadan Patients
-
Sleep-related Symptoms in Multiple System Atrophy: Determinants and Impact on disease severity
-
Slow Motion Analysis of Repetitive Tapping (SMART) test: a new means to assess bradykinesia
-
Smartphone applications in Parkinson’s disease: current data on disease monitoring, medication adherence, and movement modulation
-
Smartphone-based context awareness to improve ambulatory Parkinson’s monitoring
-
Smell and Taste in Blepharospasm
-
SNCA hypomethylation in rapid eye movement sleep behavior disorder is a potential biomarker for Parkinson’s disease
-
SNPs in SNCA, MCCC1, DLG2, GBF1, and MBNL2 are associated with Parkinson’s disease in southern Chinese populations
-
Socio-economic determinants of diagnostic latency in Parkinson’s disease patients
-
Somatosensory temporal discrimination threshold improves after unilateral HIFU subthalamotomy in asymmetrical PD
-
Spatiotemporal Changes in Substantia Nigra Neuromelanin Content from Prodromal to Clinical Parkinson’s Disease
-
Speech biometrics can predict cerebellar dysfunction in multiple sclerosis
-
Speech is a sensitive marker in premanifest Huntington’s disease: exploring acoustic, cognitive and fine motor performance
-
Spinal Cord Stimulation Improves Gait velocity but Not Freezing Episodes in PD Patient with Prior GPi-DBS: A Case Report
-
Spinal Cord Stimulation on Parkinson’s disease: Continuous or intermittent stimulation?
-
Spinocerebellar Ataxia Type 3 Presenting with Motor Neuron Disease
-
Spontaneous smoking cessation in a parkinsonian patient treated with apomorphine pump
-
Spreading ɑ-synuclein pathology initiated from the sublaterodorsal tegmental nucleus models RBD followed by Parkinsonian phenotypes in mice
-
Staircase sign for Atypical and Secondary parkinsonism
-
Stiff person syndrome and acethylcoline receptors ganglionic neuronal antibodies
-
Stiff-person spectrum disorders in Russia: a retrospective analysis of 20 cases
-
Stimulation induced dystypia after pallidal deep brain stimulation
-
Stimulation parameters of subthalamic deep brain stimulation in dystonia: a systematic review
-
Striatal neurodegeneration in the presymptomatic phase of X-linked Dystonia-Parkinsonism
-
Structural and microstructural pathology in early de novo Parkinson’s disease patients with depression: An MRI study
-
Study on the clinical features of Parkinson’s disease with probable rapid eye movement sleep behavior disorder
-
Subacute cognitive decline after DBS in a patient with idiopathic delayed-onset edema
-
Subclinical cardiac autonomic dysfunction in patients with Parkinson’s disease: A pilot study
-
Subjective Cognitive Complaints in early Parkinson’s Disease patients with normal cognition are associated with affective symptoms
-
Substantia nigra echogenicity as a predictor of drug withdrawal response in suspected drug-induced parkinsonism: a five year follow-up study
-
Substantianigral involvement on Tc99mDaTSPECT-a novel and under recognised imaging finding in Parkinsonian Disorders
-
Successful treatment of incessant purposeless groaning in Progressive Supranuclear Palsy with Pimozide
-
Sulpiride-induced Parkinsonism in Peptic Ulcer and Gastroesophageal Reflux Disease Patients: A Nationwide Population-Based Study
-
Super-Responders to Opicapone Adjunct Treatment to Levodopa in Parkinson’s Disease Patients with Motor Fluctuations: Combined Post-Hoc Analysis of BIPARK-I and II
-
Survival in Parkinson’s Disease and Association with MAPT and APOE
-
Survival in restless legs syndrome: An eleven-year surveillance, community-based population study
-
Sustained Improvement in Freezing of Gait (FOG) and Treatment Satisfaction at 12 months After Initiation of Carbidopa/Levodopa Enteral Suspension (CLES) in Advanced Parkinson’s Disease (APD) Patients in USA: Interim Results from the PROviDE Study
-
Symptomatic palatal tremor following cerebellar stroke – Clinical and neuroimaging features
-
SYNGAP1-related intellectual disability with ataxia and late onset of epileptic seizures
MDS Virtual Congress 2020
September 12-16, 2020. Virtual Congress. www.mdscongress.org